JavaScript is Disabled
Your browser's JavaScript functionality is disabled. It has to be enabled to use this function of ConfTool.
Here you can find information on how to enable JavaScript
If you have any problems, please contact the organizers at amit.pandey@unibe.ch.

Conference Agenda

Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).

Daily Overview

Session

P450 Drug Design and targeting: Symposia 7 P450 Drug Design and targeting

Time:

Wednesday, 02/July/2025:

10:00am - 12:00pm

Session Chair: Dr. Irina Pikuleva, Case Western Reserve University, United States of America
Session Chair: Dr. Edward Thomas Morgan, Emory University, United States of America

Location: Auditorium 003

199 Places

Session Topics:

7. Cytochrome P450 Drug Design and targeting

Presentations

10:00am - 10:30am

Non-Steroidal Inhibitors of CYP17A1 for Prostate Cancer Therapy

Tomasz M. Wróbel, Amit V. Pandey, Flemming S. Jørgensen, Fredrik Björkling, Jibira Yakubu, Therina du Toit, Katyayani Sharma, Jeremiah C. Harrington, Angelika Grudzińska, Oksana Rogova, Maria N. Rojas Velazquez

10:30am - 11:00am

CYP46A1 as a Pharmacologic Target for Alzheimer’s Disease and Other Brain Disorders

Chair(s): Irina Pikuleva (Case Western Reserve University, United States of America)

Presentations of the Symposium

CYP46A1 as a Pharmacologic Target for Alzheimer’s Disease and Other Brain Disorders

Irina Pikuleva
Case Western Reserve University, United States of America

11:00am - 11:15am

Targeting steroidogenic P450s with natural compounds and nanoparticles for cancer and endocrine disorders

Jibira Yakubu, Evangelos Natsaridis, Isabel B. Sousa, Oya Tagit, Amit V. Pandey

11:15am - 11:30am

Abiraterone-derived dual inhibitor targeting CYP17A1 and HDAC6 as a novel strategy to overcome temozolomide resistance in glioblastoma

Hong-Yi Lin, Tsung-I Hsu

11:30am - 12:00pm

Selective chemical inhibition of CYP3A4 and CYP3A5

Taosheng Chen